about
Nanoparticle-based monitoring of cell therapy.Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic SuccessesQuantitative Impact of Plasma Clearance and Down-regulation on GLP-1 Receptor Molecular Imaging.Imaging Pancreatic Beta-Cells: Update from the 4th Workshop of the National Institutes of Health, Washington DC, April 2009.Mouse Models for Type 1 Diabetes.A comparison of three (67/68)Ga-labelled exendin-4 derivatives for β-cell imaging on the GLP-1 receptor: the influence of the conjugation site of NODAGA as chelatorPreparation of (111)In-DTPA morpholino oligomer for low abdominal accumulation.Bioluminescence imaging of β cells and intrahepatic insulin gene activity under normal and pathological conditions.Human islet cell MORF/cMORF pretargeting in a xenogeneic murine transplant modelGlucagon-like peptide-1 (GLP-1) analogs: recent advances, new possibilities, and therapeutic implications.Enhancing Cell therapies from the Outside In: Cell Surface Engineering Using Synthetic Nanomaterials.The pancreatic beta cell surface proteome.Magnetic resonance imaging using heparin-coated superparamagnetic iron oxide nanoparticles for cell tracking in vivo.Pancreatic beta cell mass PET imaging and quantification with [11C]DTBZ and [18F]FP-(+)-DTBZ in rodent models of diabetes.Type 1 diabetes: etiology, immunology, and therapeutic strategies.Pancreas-Specific Delivery of β-Cell Proliferating Small Molecules.Use of Nanoparticle Contrast Agents for Cell Tracking with Computed Tomography.Detection of viability of transplanted beta cells labeled with a novel contrast agent - polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles by magnetic resonance imaging.Unique sphingomyelin patches are targets of a beta-cell-specific antibody.Highly efficient adenoviral transduction of pancreatic islets using a microfluidic device.Detection of pancreatic islet allograft impairment in advance of functional failure using magnetic resonance imaging.Pancreatic imaging using an antibody fragment targeting the zinc transporter type 8: a direct comparison with radio-iodinated Exendin-4.Consequences of a fat diet in the distribution of minerals within pancreatic tissues of rats and rabbits.Contrast-enhanced ultrasound measurement of pancreatic blood flow dynamics predicts type 1 diabetes progression in preclinical models.
P2860
Q27000646-93C08EB0-489A-45D6-91E8-BB381D23ED1EQ28067465-8CA04EC8-5A78-40DF-832B-3C0B5BF03FAEQ30364628-C74B7192-71A6-4952-8B9F-4CDF7DC295E0Q30433253-1A05A181-C1E2-4871-956C-D510E649BC86Q33794336-94A59AFF-050A-4AE8-A086-EB400FE14BB8Q33833281-CEEB193C-FBF4-48D3-BDE7-A37841754A84Q34014474-B5E2C487-9EF2-40E3-80F5-F3CB87C5E10DQ34673131-B520EE94-2F5D-4566-BD81-8FCDF619DFE2Q35028182-96D1703F-08A4-4519-B1BF-3E06103DFAA3Q35087846-00F75AC3-0236-4AC6-85F4-40639AF8DD02Q35142623-75D62EF5-CC8A-417D-834B-95E779EABB3DQ36013553-2FECA8D2-75A1-4DA2-AEED-C2F48112615FQ36429750-69DBFC24-7150-4886-81C7-1A92B57EEE85Q37013071-B266FC80-1D40-4285-98B0-4010B9ACC897Q37830198-EB18B8EA-84C7-46A0-A7D5-A3E002D5AF21Q38776961-403F8D9A-0F86-4328-AE60-93C7820A80CBQ39293573-88E97322-328D-4EEA-8C58-1D384EE1C391Q39394616-02E4ADAE-1DC8-45E4-A3C9-22F715DB6284Q39508703-641F6A18-7C8F-4799-82B7-CC99F4A8EFE3Q39631763-4699E64A-2B86-494F-9968-8CAE0DE8D0F8Q45798448-102C6C97-9301-41AE-811A-0FEDFA16E62AQ48139118-144B4C1B-689F-4E1A-86B8-7998F43AA884Q53107388-CC32FEB0-EB0D-4F7E-942D-795E85573323Q55083872-E74B33B9-7054-4D57-9FAB-C4C405DBEDB6
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Imaging the Beta-cell mass: why and how
@en
type
label
Imaging the Beta-cell mass: why and how
@en
prefLabel
Imaging the Beta-cell mass: why and how
@en
P2093
P2860
P356
P1476
Imaging the Beta-cell mass: why and how
@en
P2093
Carl-Henrik Brogren
Frantisek Saudek
Srirang Manohar
P2860
P356
10.1900/RDS.2008.5.6
P577
2008-05-10T00:00:00Z